Role of cytokines in atypical depression

Nordic Journal of Psychiatry

Volumn 66, Issue 3, 2012, Pages 183-188

  Yoon, Ho Kyoung ^a   Kim, Yong Ku ^a   Lee, Heon Jeong ^a   Kwon, Do Young ^b   Kim, Leen ^a  

^a College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Atypical feature; Cytokine; Depression

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATYPICAL DEPRESSION; CLINICAL FEATURE; DSM-IV; FEMALE; HUMAN; HYPERPHAGIA; HYPERSOMNIA; IN VITRO STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PHENOTYPE; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TH1 CELL; TH2 CELL;

ADULT; AGED; CYTOKINES; DEPRESSION; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EATING DISORDERS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; KOREA; MALE; MIDDLE AGED; MONOCYTES; SLEEP DISORDERS; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84862111527     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.3109/08039488.2011.611894     Document Type: Article

References (46)

1. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: High vs low CRH/NE states. Mol Psychiatry 2002;7:254-75. (Pubitemid 34280634)
2. Juruena M, Cleare A. Overlap between atypical depression, seasonal affective disorder and chronic fatigue syndrome. Revista Brasileira de Psiquiatria 2007;29 Suppl 1:S19-S26. (Pubitemid 46855588)
3. Murck H. Atypical depression spectrum disorder -N eurobiology and treatment. Acta Neuropsychiatr 2003;15:227-41. (Pubitemid 36992876)
4. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002;53:865-71. (Pubitemid 35282615)
5. Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter. Clin Chem 1994;40:288-95. (Pubitemid 24072594)
6. Maier SF, Watkins LR. Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998;105:83-107. (Pubitemid 128459559)
7. Capuron L, Ravaud A, Dantzer R. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J Clin Oncol 2000;18:2143-51. (Pubitemid 30324368)
8. Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, et al. Increased depressive ratings in patients with hepatitis Creceiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. JClin Psychopharmacol 2002;22:86-90. (Pubitemid 34101297)
9. Larson SJ, Romanoff RL, Dunn AJ, Glowa JR. Effects of interleukin-1beta on food-maintained behavior in the mouse. Brain Behav Immun 2002;16:398-410. (Pubitemid 35346203)
10. Schramm TM, Lawford BR, Macdonald GA, Cooksley WG. Sertraline treatment of interferon-alfa-induced depressive disorder. Med J Aust 2000;173:359-61.
11. Kraus MR, Schafer A, Faller H, Csef H, Scheurlen M. Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C. Aliment Pharmacol Ther 2002;16:1091-9. (Pubitemid 34680751)
12. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: Infl ammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31. (Pubitemid 43083561)
13. Kim YK, Na KS, Shin KH, Jung HY, Choi SH, Kim JB. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1044-53.
14. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: Areview. J Neurol Neurosurg Psychiatry 2005;76:469-75.
15. Dickens C, McGowan L, Clark-Carter D, Creed F. Depression in rheumatoid arthritis: A systematic review of the literature with meta-analysis. Psychosom Med 2002;64:52-60. (Pubitemid 34137399)
16. Zautra AJ, Yocum DC, Villanueva I, Smith B, Davis MC, Attrep J, et al. Immune activation and depression in women with rheumatoid arthritis. J Rheumatol 2004;31:457-63. (Pubitemid 38337602)
17. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, et al. Gender differences in chronic major and double depression. J Affect Disord 2000;60:1-11. (Pubitemid 30625239)
18. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids infl uence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000;21:55-89. (Pubitemid 32266068)
19. Bonaccorso S, Puzella A, Marino V, Pasquini M, Biondi M, Artini M, et al. Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Res 2001;105:45-55. (Pubitemid 34015882)
20. Capuron L, Ravaud A, Gualde N, Bosmans E, Dantzer R, Maes M, et al. Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 2001;26:797-808. (Pubitemid 32918284)
21. APA, editor. Diagnostic and statistical manual of mental disorders, 4th edition. Washington DC: American Psychiatric Press; 1994.
22. First M, Spitzer RL, Gibbon M, William JB. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P, version 2.0). New York: American Psychiatric Publishing, Inc.; 1998.
23. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812.
24. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
25. De Groote D, Zangerle PF, Gevaert Y, Fassotte MF, Beguin Y, Noizat- Pirenne F, et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992;4:239-48.
26. Maes M. Evidence for an immune response in major depression: Areview and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:11-38.
27. Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, et al. Infl ammatory markers in major depression and melancholia. J Affect Disord 2001;63:93-102. (Pubitemid 32200503)
28. Carroll BJ, Curtis GC, Mendels J. Cerebrospinal fl uid and plasma free cortisol concentrations in depression. Psychol Med 1976;6:235-44.
29. Maes M, Lin A, Bonaccorso S, van Hunsel F, Van Gastel A, Delmeire L, et al. Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fi bromyalgia. Acta Psychiatr Scand 1998;98:328-35. (Pubitemid 28481430)
30. Antonijevic IA, Murck H, Frieboes RM, Steiger A. Sexually dimorphic effects of GHRH on sleep-endocrine activity in patients with depression and normal controls - part II: Hormone secretion. Sleep Res Online 2000;3:15-21.
31. Casper RC, Swann AC, Stokes PE, Chang S, Katz MM, Garver D. Weight loss, cortisol levels, and dexamethasone suppression in major depressive disorder. Acta Psychiatr Scand 1987;75:243-50.
32. Miller KB, Nelson JC. Does the dexamethasone suppression test relate to subtypes, factors, symptoms, or severity? Arch Gen Psychiatry 1987;44:769-74. (Pubitemid 17152877)
33. Casper RC, Kocsis J, Dysken M, Stokes P, Croughan J, Maas J. Cortisol measures in primary major depressive disorder with hypersomnia or appetite increase. J Affect Disord 1988;15:131-40.
34. Thase ME, Himmelhoch JM, Mallinger AG, Jarrett DB, Kupfer DJ. Sleep EEG and DST findings in anergic bipolar depression. Am JPsychiatry 1989;146:329-33. (Pubitemid 19078194)
35. Maes M, Maes L, Suy E. Symptom profi les of biological markers in depression: A multivariate study. Psychoneuroendocrinology 1990;15:29-37. (Pubitemid 20173718)
36. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, infl ammation, and hematopoiesis. J Leukoc Biol 2000;68:437-46.
37. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Infl ammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 2000;148:209-14. (Pubitemid 30064452)
38. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptormediated regional sympathetic nerve activation by leptin. J Clin Invest 1997;100:270-8. (Pubitemid 27349073)
39. Plata-Salaman CR. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 2000;16:1009-12.
40. Wong S, Pinkney J. Role of cytokines in regulating feeding behaviour. Curr Drug Targets 2004;5:251-63. (Pubitemid 38372311)
41. Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR, et al. Leptin defi ciency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 1999;276:R136-R42.
42. Kapsimalis F, Richardson G, Opp MR, Kryger M. Cytokines and normal sleep. Curr Opin Pulm Med 2005;11:481-4. (Pubitemid 41564996)
43. Krueger JM. The role of cytokines in sleep regulation. Curr Pharm Des 2008;14:3408-16.
44. Krueger JM, Rector DM, Churchill L. Sleep and cytokines. Sleep Med Clin 2007;2:161-9.
45. Moldofsky H, Lue FA, Eisen J, Keystone E, Gorczynski RM. The relationship of interleukin-1 and immune functions to sleep in humans. Psychosom Med 1986;48:309-18. (Pubitemid 16117352)
46. Obal F, Jr., Krueger JM. Biochemical regulation of non-rapid-eyemovement sleep. Front Biosci 2003;8:d520-50.